In a story about the potential for college students to bring the virus home to older family members, Judy Guzman-Cottrill, D.O., recommends caution: “One negative test does not mean you are home free.”

In an article on the impact of bedtime on sleep, Teni Davoudian, Ph.D., says the time when you wake up consistently makes the biggest difference in how well-rested you feel.

A feature story highlights the first OHSU Doernbecher patient to receive a new, at-home oral treatment for spinal muscular atrophy. Erika Finanger, M.D., says the promising treatment will become more effective if given to patients early in life, suggesting the importance of newborn screening for the condition.

Story in The Atlantic quotes Esther Choo, M.D.

Renee Edwards, M.D., and Esther Choo, M.D., provide a health care perspective during a press conference hosted by Gov. Kate Brown announcing new restrictions to curtail the spread of the virus.

Brian Druker, M.D., and Ted Braun, M.D., Ph.D., co-author an invited commentary in JAMA Oncology on the “consequential” patient-reported outcomes found in a clinical trial studying chronic myeloid leukemia patients who remained in treatment-free remission after tyrosine kinase inhibition treatment discontinuation. “These findings provide objective evidence that important measures of quality of life do improve off therapy.”

Psychiatric News interviews Honora Englander, M.D., about a recent study finding that more than half of patients hospitalized with a substance use disorder use more than one substance: “The recent national focus on the ‘opioid epidemic,’ while important, may miss the mark and oversimplify patterns of substance use for many people.”

In a story about in-home tests, Donna Hansel, M.D., Ph.D., says it’s still critical to talk with your doctor: “The disease varies a lot from person to person, symptoms vary a lot, rate of progression varies person to person, and I think having a conduit to ask those questions and receive that information is very important.”

Applied Genetic Technology Corp. reports positive data from a gene-based therapy to treat X-linked retinitis pigmentosa. Paul Yang, M.D., is quoted in the news release.

A press release announces the VA Portland Health Care System and OHSU will receive $2.5 million in funding to launch a center of excellence dedicated to prostate cancer. Julie Graff, M.D., says: “This award will make it possible for us to reach out to veterans throughout Oregon and Southwest Washington to offer genetic testing and sequencing for all patients with metastatic prostate cancer.”